Technology area: Biotechnology & Pharmaceuticals
15 pending office actions • 9 art units • 13 examiners • 0 of 15 (0%) have an AI response strategy ready • 19 patents granted in the last 365 days
Illumina Cambridge Limited has 15 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 13 distinct examiners and 9 distinct art units, indicating broad examiner distribution and meaningful spread across technical groups.
CROW, ROBERT THOMAS is the busiest examiner, with 2 pending matters. That shared assignment is a useful point for targeted review, but the broader docket calls for centralized handling of biotechnology terminology, experimental support, and claim strategy across the 9 art units.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (7%) |
| §103 only | 2 (13%) |
| §102 only | 1 (7%) |
| Double-patenting + other | 2 (13%) |
| Multi-statute (no §101) | 8 (53%) |
| No statute on record | 1 (7%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CROW, ROBERT THOMAS | 2 | 41.6% | +32.5% |
| BERTAGNA, ANGELA MARIE | 2 | 44.7% | +46.3% |
| SHEDRICK, CHARLES TERRELL | 1 | 77.9% | +9.3% |
| KENNEDY, TIMOTHY J | 1 | 71.3% | +17.5% |
| TRAN, VIVIAN AILINH | 1 | 55.7% | +43.5% |
| TSAI, TSUNG YIN | 1 | 81.6% | +11.6% |
| BROWN, MINDY G | 1 | 57.8% | +40.5% |
| HORLICK, KENNETH R | 1 | 79.0% | +15.3% |
| PARISI, JESSICA DANIELLE | 1 | 75.0% | +33.5% |
| BUNKER, AMY M | 1 | 29.1% | +45.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18613562 | DENSLEY-PACKED ANALYTE LAYERS AND DETECTION METHODS | TSAI, TSUNG YIN | 34d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17946742 | SYSTEMS AND METHODS OF DETECTING DENSELY-PACKED ANALYTES | TURK, NEIL N | 20d |
| 18821807 | SYSTEMS AND METHODS FOR MEASUREMENT AND SEQUENCING OF BIO-MOLECULES | TRAN, VIVIAN AILINH | 35d |
| 18419082 | COMPOSITIONS AND METHODS FOR AMPLIFYING POLYNUCLEOTIDES | BROWN, MINDY G | — |
| 18303905 | Sequencing Templates Comprising Multiple Inserts and Compositions and Methods for Improving Sequencing Throughput | HORLICK, KENNETH R | — |
| 18169970 | Sequence-Specific Targeted Transposition and Selection and Sorting of Nucleic Acids | PARISI, JESSICA DANIELLE | — |
| 18163405 | Preparation of RNA and DNA Sequencing Libraries Using Bead-Linked Transposomes | BUNKER, AMY M | — |
| 18146320 | FLOW CELLS AND METHODS | BERTAGNA, ANGELA MARIE | — |
| 17694404 | DETECTING METHYLCYTOSINE AND ITS DERIVATIVES USING S-ADENOSYL-L-METHIONINE ANALOGS (xSAMS) | HIBSHMAN, SARAH GRACE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18613562 | DENSLEY-PACKED ANALYTE LAYERS AND DETECTION METHODS | TSAI, TSUNG YIN | 34d |
| 18821807 | SYSTEMS AND METHODS FOR MEASUREMENT AND SEQUENCING OF BIO-MOLECULES | TRAN, VIVIAN AILINH | 35d |
| 18964377 | IMPRINTING APPARATUS | KENNEDY, TIMOTHY J | — |
| 18587683 | COMPOSITIONS AND METHODS FOR DENSLEY-PACKED ANALYTE ANALYSIS | CROW, ROBERT THOMAS | — |
| 18419082 | COMPOSITIONS AND METHODS FOR AMPLIFYING POLYNUCLEOTIDES | BROWN, MINDY G | — |
| 18227657 | NUCLEIC ACID SEQUENCING METHOD AND SYSTEM EMPLOYING ENHANCED DETECTION OF NUCLEOTIDE-SPECIFIC TERNARY COMPLEX FORMATION | BERTAGNA, ANGELA MARIE | — |
| 18303905 | Sequencing Templates Comprising Multiple Inserts and Compositions and Methods for Improving Sequencing Throughput | HORLICK, KENNETH R | — |
| 18169970 | Sequence-Specific Targeted Transposition and Selection and Sorting of Nucleic Acids | PARISI, JESSICA DANIELLE | — |
| Art Unit | Apps |
|---|---|
| 1683 | 3 |
| 1681 | 3 |
| 1684 | 2 |
| 2646 | 1 |
| 1794 | 1 |
| 2656 | 1 |
| 1685 | 1 |
| 1798 | 1 |
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19002476 | DEEP LEARNING-BASED VARIANT CLASSIFIER | SHEDRICK, CHARLES TERRELL | 2646 | §102Other | Non-Final OA | — | Pending | Dec 26, 2024 |
| 18964377 | IMPRINTING APPARATUS | KENNEDY, TIMOTHY J | — | Other | Non-Final OA | — | Pending | Nov 30, 2024 |
| 18821807 | SYSTEMS AND METHODS FOR MEASUREMENT AND SEQUENCING OF BIO-MOLECULES | TRAN, VIVIAN AILINH | 1794 | §103§112 | Final Rejection | 35d | Pending | Aug 30, 2024 |
| 18613562 | DENSLEY-PACKED ANALYTE LAYERS AND DETECTION METHODS | TSAI, TSUNG YIN | 2656 | §103 | Non-Final OA | 34d | Pending | Mar 22, 2024 |
| 18587683 | COMPOSITIONS AND METHODS FOR DENSLEY-PACKED ANALYTE ANALYSIS | CROW, ROBERT THOMAS | 1683 | §103§112DP | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18419082 | COMPOSITIONS AND METHODS FOR AMPLIFYING POLYNUCLEOTIDES | BROWN, MINDY G | 1685 | §103§112Other | Non-Final OA | — | Pending | Jan 22, 2024 |
| 18227657 | NUCLEIC ACID SEQUENCING METHOD AND SYSTEM EMPLOYING ENHANCED DETECTION OF NUCLEOTIDE-SPECIFIC TERNARY COMPLEX FORMATION | BERTAGNA, ANGELA MARIE | 1681 | §102§103§112DP | Non-Final OA | — | Pending | Jul 28, 2023 |
| 18303905 | Sequencing Templates Comprising Multiple Inserts and Compositions and Methods for Improving Sequencing Throughput | HORLICK, KENNETH R | 1681 | §103§112 | Non-Final OA | — | Pending | Apr 20, 2023 |
| 18169970 | Sequence-Specific Targeted Transposition and Selection and Sorting of Nucleic Acids | PARISI, JESSICA DANIELLE | 1684 | §103§112 | Final Rejection | — | Pending | Feb 16, 2023 |
| 18163405 | Preparation of RNA and DNA Sequencing Libraries Using Bead-Linked Transposomes | BUNKER, AMY M | 1684 | §102§103§112 | Final Rejection | — | Pending | Feb 02, 2023 |
| 18146320 | FLOW CELLS AND METHODS | BERTAGNA, ANGELA MARIE | 1681 | §103§112 | Final Rejection | — | Pending | Dec 23, 2022 |
| 17946742 | SYSTEMS AND METHODS OF DETECTING DENSELY-PACKED ANALYTES | TURK, NEIL N | 1798 | §101§112 | Final Rejection | 20d | Pending | Sep 16, 2022 |
| 17694404 | DETECTING METHYLCYTOSINE AND ITS DERIVATIVES USING S-ADENOSYL-L-METHIONINE ANALOGS (xSAMS) | HIBSHMAN, SARAH GRACE | 1693 | §102§103§112 | Non-Final OA | — | Pending | Mar 14, 2022 |
| 17555945 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID SEQUENCING | HOPPE, EMMA RUTH | 1683 | §103 | Non-Final OA | 46d overdue | Pending | Dec 20, 2021 |
| 17338590 | SYSTEMS AND METHODS FOR SEQUENCING NUCLEOTIDES USING TWO OPTICAL CHANNELS | CROW, ROBERT THOMAS | 1683 | §103§112 | Non-Final OA | — | Pending | Jun 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialIllumina Cambridge Limited has 15 pending office actions as of October 2026, spread across 9 art units and 13 examiners.
Robert Thomas Crow has the most, with 2 of Illumina Cambridge Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
